Proliferation behavior of E. coli in a three-dimensional in vitro tumor model

被引:12
作者
Elliott, Nelita [1 ]
Lee, Tae [1 ]
You, Lingchong [1 ]
Yuan, Fan [1 ]
机构
[1] Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA
基金
美国国家科学基金会;
关键词
CULTURED-MAMMALIAN-CELLS; SALMONELLA-TYPHIMURIUM; MICROFLUIDIC PLATFORM; GENE DELIVERY; LISTERIA-MONOCYTOGENES; INTRACELLULAR BACTERIA; MULTICELL SPHEROIDS; TARGETED SALMONELLA; ANTICANCER DRUGS; EPITHELIAL-CELLS;
D O I
10.1039/c0ib00137f
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Advances in genetic engineering of non-pathogenic Escherichia coli (E. coli) have made this organism an attractive candidate for gene delivery vehicle. However, proliferation and transport behaviors of E. coli in three-dimensional (3D) tumor environment are still unclear. To this end, we developed a novel microfluidics-based tumor model that permitted direct in situ visualization of E. coli in a 3D environment with densely packed tumor cells (B16.F10 or EMT6). The E. coli was engineered to co-express two proteins invasin and mCherry (inv(+)) so that they had the ability to enter mammalian cells and could be visualized via fluorescence microscopy. E. coli expressing mCherry alone (inv(-)) was used as the control counterpart. The inv(-) bacteria proliferated to a higher extent than inv(+) bacteria in both the 3D tumor model and a 2D monolayer culture model. Meanwhile, the proliferation appeared to be tumor cell type dependent since bacteria did not proliferate as well in the EMT6 model compared to the B16.F10 model. These differences in bacterial proliferation were likely to be caused by inhibitors secreted by tumor cells, as suggested by our data from the bacterial-tumor cell monolayer co-culture experiment. The bacterial proliferation provided a driving force for E. coli spreading in the 3D interstitial space of tumors. These findings are useful for researchers to develop novel strategies for improvement of bacteria-mediated oncolysis or gene delivery in cancer treatment.
引用
收藏
页码:696 / 705
页数:10
相关论文
共 71 条
[11]   Potential therapeutic applications of recombinant, invasive E. coli [J].
Critchley, R ;
Jezzard, S ;
Radford, KJ ;
Goussard, S ;
Lemoine, NR ;
Grillot-Courvalin, C ;
Vassaux, G .
GENE THERAPY, 2004, 11 (15) :1224-1233
[12]  
Critchley Rebecca J, 2004, Discov Med, V4, P194
[13]   MULTICELL SPHEROIDS AS A MODEL FOR CELL KINETIC-STUDIES [J].
DURAND, RE .
CELL AND TISSUE KINETICS, 1990, 23 (03) :141-159
[14]   A Review of Three-Dimensional In Vitro Tissue Models for Drug Discovery and Transport Studies [J].
Elliott, Nelita T. ;
Yuan, Fan .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 100 (01) :59-74
[15]  
ELLIOTT NT, 2010, THESIS DUKE U DURHAM
[16]  
FALKOW S, 1992, ANNU REV CELL BIOL, V8, P333, DOI 10.1146/annurev.cb.08.110192.002001
[17]  
Forbes NS, 2003, CANCER RES, V63, P5188
[18]  
FREYER JP, 1983, ADV EXP MED BIOL, V159, P463
[19]   Genetically engineered bifidobacterium as a drug delivery system for systemic therapy of metastatic breast cancer patients. [J].
Fujimori M. .
Breast Cancer, 2006, 13 (1) :27-31
[20]   Tumour-targeted delivery of TRAIL using Salmonella typhimurium enhances breast cancer survival in mice [J].
Ganai, S. ;
Arenas, R. B. ;
Forbes, N. S. .
BRITISH JOURNAL OF CANCER, 2009, 101 (10) :1683-1691